Hsiang‐Ling Ho - Concepedia

Author

Hsiang‐Ling Ho

National Yang Ming Chiao Tung University

Also Known As

Fu-Pang Chang, Hsiang-Ling Ho, Hsiang‐Ling Ho, Hsiang‑Ling Ho

Publications

811

Citations

H-Index

Concepts

All Affiliations

National Yang Ming Chiao Tung University Taipei Veterans General Hospital National Yang Ming University Hospital Taipei Medical University Hospital

About

Hsiang‐Ling Ho is an author at National Yang Ming Chiao Tung University specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	382
2	Cell Biology	4	4	110
3	Health Sciences	3	3	60
4	Natural Sciences	1	1	35
5	Cellular Physiology	1	1	35

Hsiang‐Ling Ho

Publications

664

Citations

H-Index

Page 1

	Year	Citations
C-Reactive Protein (CRP) is a Promising Diagnostic Immunohistochemical Marker for Intrahepatic Cholangiocarcinoma and is Associated With Better Prognosis Yi‐Chen Yeh, Hao-Jan Lei, Ming‐Huang Chen, The American Journal of Surgical Pathology	2017	54
Epstein-Barr Virus–Associated Pulmonary Carcinoma Yi‐Chen Yeh, Hua‐Lin Kao, Kang-Lung Lee, The American Journal of Surgical Pathology Lymphoid NeoplasiaRare Epstein-barr VirusMedicineMultiple Pulmonary NoduleImmunology	2018	46
PD-L1 Expression of Tumor Cells, Macrophages, and Immune Cells in Non–Small Cell Lung Cancer Patients with Malignant Pleural Effusion Yen-Han Tseng, Hsiang‐Ling Ho, Chiung‐Ru Lai, Journal of Thoracic Oncology Cancer ImmunosurveillancePd-l1 ExpressionLung InflammationImmunologyTumor Immunity	2017	41
PD-L1 is a double-edged sword in colorectal cancer: the prognostic value of PD-L1 depends on the cell type expressing PD-L1 Hsiang‐Ling Ho, Teh‐Ying Chou, Shung-Haur Yang, Journal of Cancer Research and Clinical Oncology MedicineColorectal CancerPathologyDouble-edged SwordCancer Genomics	2019	36
Saccharomyces cerevisiaeTSC11/AVO3 participates in regulating cell integrity and functionally interacts with components of the Tor2 complex Hsiang‐Ling Ho, Yu-Shih Shiau, Mei‐Yu Chen Current Genetics Signal TransductionCell IntegrityNatural SciencesTor2 ComplexMolecular Biology	2005	35
Upregulation of miR-125b, miR-181d, and miR-221 Predicts Poor Prognosis in MGMT Promoter-Unmethylated Glioblastoma Patients Yen‐Ying Chen, Hsiang‐Ling Ho, Shih‐Chieh Lin, American Journal of Clinical Pathology	2018	35
AKT1 internal tandem duplications and point mutations are the genetic hallmarks of sclerosing pneumocytoma Yi‐Chen Yeh, Hsiang‐Ling Ho, Yu–Chung Wu, Modern Pathology Point MutationsGenetic DisorderGeneticsPathologyGenetic Hallmarks	2019	35
Seroprevalence of COVID-19 in Taiwan revealed by testing anti-SARS-CoV-2 serological antibodies on 14,765 hospital patients Hsiang‐Ling Ho, Fangyu Wang, Hao-Ru Lee, The Lancet Regional Health - Western Pacific	2020	28
Prognosis of glioblastoma with faint MGMT methylation-specific PCR product Chih‐Yi Hsu, Hsiang‐Ling Ho, Shih‐Chieh Lin, Journal of Neuro-Oncology Neuro-oncologyTumoral PathologyMedicinePathologyHigh-grade Gliomas	2015	26
Exclusion of Histiocytes/Endothelial Cells and Using Endothelial Cells as Internal Reference Are Crucial for Interpretation of MGMT Immunohistochemistry in Glioblastoma Chih‐Yi Hsu, Shih‐Chieh Lin, Hsiang‐Ling Ho, The American Journal of Surgical Pathology Tumor InnervationMgmt Promoter MethylationPathologyHigh-grade GliomasGlioma	2013	22

Page 1